| 翻訳と辞書 |
| United Therapeutics ： ウィキペディア英語版 |
United Therapeutics
United Therapeutics is a biotechnology company.〔(America's Best Small Companies: #12 United Therapeutics )〕 It is listed on the NASDAQ.〔(Yahoo! Finance: United Therapeutics Corporation (UTHR) )〕〔(Commit To Buy United Therapeutics At $105, Earn 9% Annualized Using Options ), ''Forbes'', September 25, 2014〕 It has headquarters in Silver Spring, Maryland, with additional facilities in Research Triangle Park, North Carolina and Chertsey, Surrey, UK.〔United Therapeutics Corp. ("Locations." ) Accessed 2015-10-04.〕
==History==
United Therapeutics was founded in 1996 by Martine Rothblatt, an American lawyer, author, and entrepreneur. In 1994, then-Martin Rothblatt's young daughter was diagnosed with a fatal orphan disease, pulmonary arterial hypertension (PAH).〔 Rothblatt sold her telecom stock and started the $3 million PPH Cure Foundation to fund PAH research. 〔〔 By 2002 the FDA had approved United Therapeutics new drug Remodulin. an alternative to GlaxoSmithKline’s Flolan.〔 In 2002 Remodulin was priced at $90,000 per year and within "a year annual sales were $50 million."〔 By 2010 sales rose to $300 million.〔
By 2010 "United Therapeutics shares had increased 800% from 1999 when the company went public.〔
By October 2012, United Therapeutics had a market capitalization of US$3 billion.〔 Rothblatt received a total compensation of $31,581,896 in 2014. According to the "annual collaborative report" from Equilar and The New York Times, Hoppenot ranked 24th in the list of "200 highest-paid CEOs of large publicly traded companies" and fourth in the list of biopharmaceutical executives with the highest total compensation.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「United Therapeutics」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|